| Drug Name: | Ethionamide (536-33-4) |
|---|---|
| PubChem ID: | 2761171 |
| SMILES: | CCC1=NC=CC(=C1)C(=S)N |
| InchiKey: | AEOCXXJPGCBFJA-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents, Antimetabolites, Antitubercular Agents, Fatty Acid Synthesis Inhibitors, Hypolipidemic Agents |
| Molecular Weight (dalton) | : | 166.249 |
| LogP | : | 1.2782 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 38.91 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Isoniazid (54-85-3) | Acute Psychotic Reaction | Additive | Not understood | Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis |
| Cycloserine (68-41-7) | Neurotoxicity | Additive | Not known | Reversible pellagra-like encephalopathy with ethionamide and cycloserine |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category